What are the causes of calcium deposits in soft tissues?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Calcium Deposits in Soft Tissues

Calcium deposits in soft tissues occur primarily through five mechanisms: elevated calcium-phosphate product (metastatic calcification), local tissue damage (dystrophic calcification), abnormal bone metabolism, iatrogenic causes from medications, and idiopathic processes.

Primary Mechanisms

1. Elevated Calcium-Phosphate Product (Metastatic Calcification)

The most critical factor is an elevated calcium-phosphate (Ca-P) product, particularly when it exceeds 55 mg²/dL² 1. This occurs most commonly in:

  • Chronic kidney disease (CKD): Phosphorus levels typically rise from 3.5 to 7 mg/dL (factor of 2), while calcium rises from 9.5 to 11 mg/dL (factor of 1.2), making hyperphosphatemia the dominant driver 1
  • Hyperparathyroidism: Excess PTH mobilizes calcium from bone, raising serum calcium 1, 2
  • Hypervitaminosis D: Excessive vitamin D increases intestinal calcium absorption 2
  • Malignancy: Bone metastases or paraneoplastic syndromes elevate calcium 3

Key point: In CKD Stage 5, serum phosphorus elevation is more important than calcium elevation in generating high Ca-P product 1.

2. Iatrogenic Causes

Medications directly cause soft tissue calcification:

  • Calcium-based phosphate binders: Particularly problematic in CKD patients with low-turnover bone disease 1
  • Active vitamin D sterols: Calcitriol and analogs increase calcium absorption, leading to hypercalcemia 1
  • High dialysate calcium: Concentrations of 1.75 mmol/L are associated with vascular calcification 4

Critical threshold: Total elemental calcium intake (dietary plus supplements) should not exceed 2,000 mg/day 1.

3. Dystrophic Calcification (Local Tissue Damage)

Calcium deposits in damaged tissue despite normal serum calcium and phosphate 5, 6:

  • Connective tissue diseases: Scleroderma (affects 25% of patients), dermatomyositis, systemic lupus erythematosus 7, 6
  • Chronic inflammation: Prolonged tissue injury creates conditions favoring calcium precipitation 7
  • Vascular damage: Arteriosclerosis, chronic ischemia 6
  • Trauma: Repeated microtrauma or major injury 7

4. Bone Metabolism Disorders

CKD-mineral and bone disorder (CKD-MBD) creates a complex cascade 1:

  • Reduced 1,25(OH)₂D production decreases intestinal calcium absorption
  • Secondary hyperparathyroidism develops from chronic hypocalcemia
  • Elevated PTH mobilizes calcium from bone
  • Hyperphosphatemia from reduced renal excretion
  • Elevated FGF23 contributes to vascular calcification 8

This leads to calcification of lungs (pulmonary fibrosis, hypertension), myocardium (heart failure, arrhythmias), coronary arteries (ischemic disease), and cardiac valves 1.

5. Additional Contributing Factors

Multiple factors beyond Ca-P product influence soft tissue calcification 1:

  • Advanced age: Negative calcium balance in elderly 1
  • Low-turnover bone disease: Reduced bone buffering capacity for calcium loads 1
  • Vascular hypoxia: Chronic ischemia promotes calcification 7
  • Dysregulation of bone matrix proteins: Abnormal expression of osteogenic factors 7, 9
  • Alkaline phosphatase elevation: Promotes calcium-phosphate precipitation 9

Clinical Subtypes

Metastatic Calcification

Normal tissue calcification with abnormal calcium/phosphate metabolism 5, 6, 10

Dystrophic Calcification

Damaged tissue calcification with normal metabolism 5, 6

Calcinosis

Subcutaneous/skin calcification with normal metabolism, seen in autoimmune diseases 6

Calciphylaxis

Small vessel calcification with dermal/subcutaneous involvement, associated with hyperparathyroidism 5

Tumoral Calcinosis

Large periarticular calcium deposits, often invalidating, difficult to treat 11, 6

Common Pitfalls

Do not assume soft tissue calcification always correlates with high Ca-P product—many other factors are involved 1. The relationship is probabilistic, not deterministic.

Recognize that in CKD patients, corrected calcium (adjusted for albumin) must be used: Corrected calcium (mg/dL) = Total calcium + 0.8 × [4 - Serum albumin (g/dL)] 1.

Monitor patients on calcium-based binders and vitamin D therapy closely, as hypercalcemia is frequent and can be life-threatening 1.

References

Guideline

multiple myeloma, version 2.2024, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2023

Research

Calcinosis cutis: part I. Diagnostic pathway.

Journal of the American Academy of Dermatology, 2011

Research

A review of soft tissue calcifications.

The Journal of foot surgery, 1985

Research

Calcinosis in scleroderma.

Current opinion in rheumatology, 2018

Research

The mechanism of calcium deposition in soft tissues.

Contributions to nephrology, 2005

Research

Metastatic Calcinosis of Gastric Mucosa.

Journal of investigative medicine high impact case reports, 2020

Research

A clinical approach to the uraemic patient with extraskeletal calcifications.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.